<html>

<head>
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet">
    <link href="./static/css/outliers.css" rel="stylesheet">
    <meta charset="UTF-8">
</head>

<body>
    <div class="container">
        <h1>Static outliers for Park Surgery</h1>
        <p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
            explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to: identify unusual prescribing, collect feedback on this prescribing to inform development of new tools to support
            prescribers and organisations to audit and review prescribing.</p>
        <p>The below reports have been developed to use “z-scores” to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. It is important to remember that
            this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not. Our full analytical
            method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a> but briefly we calculate the number of prescriptions for each chemical in the BNF coding system using the BNF subparagraph as a denominator.
            We used the time period from 1 April 2021 to 1 August 2021. We then calculate the mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs. From this we can calculate the “z-score”, which is a measure
            of how many standard deviations a given practice/CCG/PCN is from the population mean. We then rank your “z-scores” to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier
            for prescribing lower than its peers.</p>
        <p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&entry.2016356131=+">survey</a>            or emailing us at
            <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed
            feedback.
        </p>
        <h2>Prescribing where Park Surgery is higher than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82039&amp;numIds=1002020Z0&amp;denomIds=10.2.2&amp;selectedTab=summary">Pridinol mesilate</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>5</td>
      <td>Skeletal muscle relaxants</td>
      <td>34</td>
      <td>0.15</td>
      <td>0.00</td>
      <td>0.01</td>
      <td>15.34</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82039&amp;numIds=1002020Z0AAAAAA&amp;denomIds=10.2.2&amp;selectedTab=summary" target="_blank">Pridinol 3mg tablets : 5</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82039&amp;numIds=1305020S0&amp;denomIds=13.5.2&amp;selectedTab=summary">Salicylic acid</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>4</td>
      <td>Preparations for psoriasis</td>
      <td>107</td>
      <td>0.04</td>
      <td>0.00</td>
      <td>0.01</td>
      <td>3.82</td>
      <td><img class="zoom" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAPwAAABICAYAAADS8JgEAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAHnUlEQVR4nO3da4xeRR3H8e/pdis2JdIAQmKko6UkRTGokLheIIrG6olJBbRp6g1DQIkaX4gZ0EReQDKGaASjTSBcrEpiTbQvOuClXmKNGhs0RhoToeVU4gVUerPQ3V7GFzNLny77tM/ucy67O79PcnKebp+d/3/b/Z+ZM8+cc4oQAiKSh0VdJyAi7VHBi2REBS+SERW8SEZU8CIZUcGLZEQFL5IRFbxIRlTwIhlRwYtkRAU/G0Wh9cgyLy3uIqix/hZgFPhy5crxLnIQyVHrPbyx/qXATcD5wKPG+re1nYNIrroY0q8Fflq58ibgeuDrxvp7jPXLO8hFJCtdFPx1wAMAlSt/B1wO7Cb29uuM9UUHOYlkodWCN9ZfAKwAfj35tcqVRypXOuBdxB7/m23mJJKTtnv4jwCbKle+aJa7cuUu4D3A64z117acl0gWWiv4NFT/MLCp33sqVx4FPgTcaax/RVu5ieSizR7+rcCeypVPnepNlSufBG4DHjDWa52ASI3aLKgXJusGsAnYD3ymuXRE8tNKwRvrlxEn5bYM8v50jn8j8Glj/SVN5iaSk7Z6+GuBrZUrnx/0GypXPkss+m8b689oLDORjLRV8DMZzr+gcuU24OfAHbVnJJKhxgveWL8SOBvYMcsmbgWuMtZfVV9WInlqo4f/GPDgdJ+9D6Jy5WHix3n3GusvrjMxkdw0WvDG+hFgA/CdYdqpXPln4OPAVmP9ZXXkJpKjpnv4dwA7K1f+a9iGKlf+ElgHbDbWXzlseyI5arrgZzVZ10/lyh3A+4D7jfVlXe2K5KKxgjfWn0VcXbe1znYrV+4kfqb/VWP9+jrbFlnomuzh1wE/qFw5UXfDlSt3A28HbjHW31h3+yILVZMFX+twfqrKlf8gFv31KnqRwTRS8Mb61cCSypV/aqL9SZUr/wusAT5lrP9gk7FEFoKmevhGe/dePUV/u7H+3W3EFJmvai94Y/1i4vn7Q3W33U/lyr8DJbDRWD/WVlyR+aaJHn4NsCP1vK2pXPk4cA3wkLH+tW3GFpkvmij41obzU1Wu/CPxNlpbjPWv6iIHkbms1oI31p8DvBH4cZ3tzkTlyu3AZ4GHdZsskZPV3cNvAL6X7k3XmcqVW4EvAb8x1n8jXbEnkr26C76z4fxUlSs3A6uBx4i9/WZj/eUdpyXSqSKEep6LaKy/FNhYuXLOzZKnq/beD9wMPAfcDWyrXHlwVg0WRSAEPTBD5p06C/4u4pVx99TSYAPSrbKvID7w4kpgD7Atbb+vXHlkoIZU8DJP1VLwxvolwBPAJZUr9w/dYAtS8V9MvBDnncDrgUeBHwGPpNtlT08FL/NUXQV/DXB15coNw6fUjXTQehNxHcF7gZcADwOPANtPeqy1Cl7mqbqeD38d8LWa2upEuqrvV2m7NX2ktwb4JPAtY/2TxFHM4xVgrH8D8ETlygMdpSwyY0MXfLq55Gri3WUXjLRc9z7gPmP9KGCAVcCF6S13ABca65cCFelg0LOvgAkgAMfTPgDHm7hkWGQQQw/pjfXbgZvTo5/z0DOkTweDFcQDwaqe/QriAXVR2oq0HwFGgWeIk4Z/S9se4D/AEeKBYqLP65O+NujNQVOeLyeeqjw18ASlLCh1FHwx2zvSzltDnsOnZ+adC1wwZTuHeDBYMs2+3+uCeBDYC+zr2ZYA5wHnA8uBY8DT6b2vBMaB3WnbRRyR7AMOAv+bsh/P7v94gartY7mszLFJuzTh+DJiYZ+V9hPEAn8a2Fu58viU71kGvLpnM6mNZcCZPfsziaMCiKckBfEUZRx4HjhAPCgc6Hl9KL2X9H5O8xriAWl8ynYYOEocFS3u2U+OnI5y8ohncgRUcOKgOLktAc6Y8nNNvl7KiVOvY2nf+3q6r40TD4iH0n5yO5zyG+3Zj6bcj07zM06k9hYNuI30/NtNniI+yKBCCENtwA3DtjHfc8g9/lzIIff4g251LK29oYY2htV1DrnHh+5zyD3+QPT8dZGMqOBFMlJHwc+FtfNd55B7fOg+h9zjD0Sz9CIZ0ZBeJCMzWlpbFMUVwJuBZ0II9xdFcTWwkricdCfxjjd7QwiNras/TQ770t8dDCHc3Xb8EMIPi6JYD6wIIbi24wO/Jc4W7wohfLeD+P8mXna8PITwuSbi98lhLbAmhPCJqX/XQfy1wKXAX0MIrd25eVAz7eHH0i/yuenPq0IIdwIXEW8TfTsnFmk0pW8OIYRfAA44u4v4RVG8Bvhng7FPGR/4ALCfuJCji/jjxOW7zzUY/0U5hBC2EFcKTpdfq/HT668QVzPOOTMt+Kkn/F1MAJwuh88D93YUf4x4dH9LR/FHiZfzru4o/kXAF4ir3Zp0qt+7Nn4n+8YoimKE+Du4sYU8ZmxGk3ZpKDMGPAv8gXiByEri1WF/AdYTh/R31Z/qQDmcB1wG/CSE8P2246ejO0VR2IaH9P1+/seAjwLHQgi3dRD/EPGJwSMhhC82Eb9PDkuJReaIS0/HiMPtRu6veJr4JfFU+WchhM7u3tyPZulFMqJZepGMqOBFMqKCF8mICl4kIyp4kYyo4EUyooIXyYgKXiQjKniRjKjgRTKighfJyP8BqI+u1cz6yxUAAAAASUVORK5CYII="></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82039&amp;numIds=1305020S0AAABAB&amp;denomIds=13.5.2&amp;selectedTab=summary" target="_blank">Salicylic acid 2% ointment : 4</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82039&amp;numIds=0604020M0&amp;denomIds=6.4.2&amp;selectedTab=summary">Testosterone enantate</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>6</td>
      <td>Male sex hormones and antagonists</td>
      <td>276</td>
      <td>0.02</td>
      <td>0.00</td>
      <td>0.01</td>
      <td>3.13</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82039&amp;numIds=0604020M0AAAAAA&amp;denomIds=6.4.2&amp;selectedTab=summary" target="_blank">Testosterone enantate 250mg/1ml inj ampoules : 6</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82039&amp;numIds=020400060&amp;denomIds=2.4&amp;selectedTab=summary">Celiprolol hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>15</td>
      <td>Beta-adrenoceptor blocking drugs</td>
      <td>2846</td>
      <td>0.01</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>3.07</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82039&amp;numIds=020400060BBAAAA&amp;denomIds=2.4&amp;selectedTab=summary" target="_blank">Celectol 200mg tablets : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82039&amp;numIds=020400060AAAAAA&amp;denomIds=2.4&amp;selectedTab=summary" target="_blank">Celiprolol 200mg tablets : 13</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82039&amp;numIds=0205020H0&amp;denomIds=2.5.2&amp;selectedTab=summary">Methyldopa</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>21</td>
      <td>Centrally-acting antihypertensive drugs</td>
      <td>23</td>
      <td>0.91</td>
      <td>0.16</td>
      <td>0.25</td>
      <td>2.99</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82039&amp;numIds=0205020H0AAADAD&amp;denomIds=2.5.2&amp;selectedTab=summary" target="_blank">Methyldopa 250mg tablets : 21</a></div></td></tr></tbody></table>

        <h2>Prescribing where Park Surgery is lower than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82039&amp;numIds=1001022K0&amp;denomIds=10.1.2&amp;selectedTab=summary">Methylprednisolone acetate</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Local corticosteroid injections</td>
      <td>57</td>
      <td>0.00</td>
      <td>0.73</td>
      <td>0.39</td>
      <td>-1.87</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82039&amp;numIds=0206040AE&amp;denomIds=2.6.4&amp;selectedTab=summary">Naftidrofuryl oxalate</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Peripheral vasodilators and related drugs</td>
      <td>20</td>
      <td>0.00</td>
      <td>0.66</td>
      <td>0.39</td>
      <td>-1.69</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82039&amp;numIds=0205020M0&amp;denomIds=2.5.2&amp;selectedTab=summary">Moxonidine</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>2</td>
      <td>Centrally-acting antihypertensive drugs</td>
      <td>23</td>
      <td>0.09</td>
      <td>0.64</td>
      <td>0.34</td>
      <td>-1.66</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82039&amp;numIds=0205020M0AAAAAA&amp;denomIds=2.5.2&amp;selectedTab=summary" target="_blank">Moxonidine 200microgram tablets : 2</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82039&amp;numIds=0704050Z0&amp;denomIds=7.4.5&amp;selectedTab=summary">Sildenafil (Erectile Dysfunction)</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>227</td>
      <td>Drugs for erectile dysfunction</td>
      <td>354</td>
      <td>0.64</td>
      <td>0.77</td>
      <td>0.09</td>
      <td>-1.34</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82039&amp;numIds=0704050Z0AAAAAA&amp;denomIds=7.4.5&amp;selectedTab=summary" target="_blank">Sildenafil 50mg tablets : 112</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82039&amp;numIds=0704050Z0AAACAC&amp;denomIds=7.4.5&amp;selectedTab=summary" target="_blank">Sildenafil 100mg tablets : 102</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82039&amp;numIds=0704050Z0AAABAB&amp;denomIds=7.4.5&amp;selectedTab=summary" target="_blank">Sildenafil 25mg tablets : 13</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82039&amp;numIds=0302000K0&amp;denomIds=3.2&amp;selectedTab=summary">Budesonide</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>104</td>
      <td>Corticosteroids (respiratory)</td>
      <td>1711</td>
      <td>0.06</td>
      <td>0.16</td>
      <td>0.08</td>
      <td>-1.22</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82039&amp;numIds=0302000K0BDABAM&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Symbicort 200/6 Turbohaler : 42</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82039&amp;numIds=0302000K0BGABAG&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Easyhaler Budesonide 200micrograms/dose dry powder inhaler : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82039&amp;numIds=0302000K0BBAKAK&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Pulmicort 100 Turbohaler : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82039&amp;numIds=0302000K0BDADBB&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Symbicort 200microg/dose / 6microg/dose pressurised inh : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82039&amp;numIds=0302000K0BHABAU&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">DuoResp Spiromax 320microg/dose / 9microg/dose dry pdr inh : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82039&amp;numIds=0302000K0BHAAAM&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">DuoResp Spiromax 160microg/dose / 4.5microg/dose dry pdr inh : 4</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82039&amp;numIds=0302000K0AAAIAI&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Budesonide 1mg/2ml nebuliser liquid unit dose vials : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82039&amp;numIds=0302000K0BDACAU&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Symbicort 400/12 Turbohaler : 25</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82039&amp;numIds=0302000K0BBAHAG&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Pulmicort 200 Turbohaler : 10</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82039&amp;numIds=0302000K0AAAMAM&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Budesonide 200mcg/dose / Formoterol 6mcg/dose dry powder inh : 5</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82039&amp;numIds=0302000K0AABBBB&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Budesonide 200microg / Formoterol 6microg/dose inh CFC free : 5</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=H82039&amp;numIds=0302000K0BDAAAL&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Symbicort 100/6 Turbohaler : 5</a></div></td></tr></tbody></table>

    </div>
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"></script>
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"></script>
</body>

</html>